期刊文献+

蒲灵化瘀止痛方对子宫腺肌病模型小鼠异位和在位内膜血管生成相关因子的影响 被引量:4

Influence of Pu Ling Hua Yu Zhi Tong Prescription on Angiogenesis-related Factors of Ectopic and Eutopic Endometrium in Mice with Adenomyosis
下载PDF
导出
摘要 目的:探讨蒲灵化瘀止痛方对子宫腺肌病(Adenomyosis,ADM)小鼠异位及在位内膜血管内皮生长因子(VEGF)、内皮抑素(ENS)、微血管密度(MVD)表达的影响,从血管生成相关因子的角度揭示蒲灵化瘀止痛方治疗ADM的作用机理。方法:造模饲养3个月建立小鼠ADM模型。将ADM小鼠随机分为蒲灵化瘀止痛方高、中、低剂量组,丹莪妇康煎膏组,孕三烯酮组,模型组,空白组,连续给药12周后,采用HE染色法观察不同组子宫内膜腺体与间质侵入子宫肌层的程度;采用免疫组化SP法染色检测异位和在位子宫内膜的VEGF、ENS的表达,并通过CD31标记异位子宫内膜血管内皮细胞,测定其MVD。结果:蒲灵化瘀止痛方高、中剂量组能降低模型小鼠异位和在位内膜VEGF的表达(P<0.01),降低模型组小鼠异位内膜VEGF/ENS的比值(P<0.01),有下调模型小鼠在位内膜VEGF/ENS比值的趋势。结论:蒲灵化瘀止痛方减少经量的机制可能是抑制在位内膜血管生成,减少在位内膜血管数量;蒲灵化瘀止痛方缩小病灶、减轻痛经程度的机制可能是抑制异位内膜血管生成,减少异位内膜血管数量。 Objective: To reveal the mechanism of Pu Ling Hua Yu Zhi Tong prescription in treating adenomyosis(ADM) from the angles of angiogenesis-related factors by exploring the influence of Pu Ling Hua Yu Zhi Tong prescription on the expressions of vascular endothelial growth factor(VEGF), endostatin(ENS) and microvessel density(MVD) in ectopic and eutopic endometrium of mice with ADM. Methods: ADM mice models were prepared by feeding in three months. ADM mice were randomly allocated to high, moderate and low dose groups of Pu Ling Hua Yu Zhi Tong prescription, Dan EFu Kang extract group, gestrinone group, the model group and the blank group, after medicating for 12 consecutive weeks, the degrees of endometrial gland and stroma invading myometrium in different groups were observed by HE staining method; the expressions of VEGF and ENS in ectopic and eutopic endometrium detected by immunohistochemical SP staining method, and MVD measured by marking vascular endothelial cells of ectopic endometrium with CD31. Results: Pu Ling Hua Yu Zhi Tong prescription in high and moderate doses could lower the expressions of VEGF in ectopic and eutopic endometrium(P〈0.01), it could decrease the ratio of VEGF/ENS of ectopic endometrium of the mice in the model group(P〈0.01), and showed the trend of lowering the ratio of VEGF/ENS in eutopic endometrium of the mice. Conclusion: Pu Ling Hua Yu Zhi Tong prescription reducing menstrual blood volume is through inhibiting the angiogenesis of eutopic endometrium and decreasing the number of blood vessels in eutopic endometrium. The mechanism of Pu Ling Hua Yu Zhi Tong prescription narrowing the focus and alleviating the dysmenorrheal is by inhibiting the angiogenesis of ectopic endometrium and reducing the number of blood vessels in ectopic endometrium.
出处 《西部中医药》 2014年第11期17-21,共5页 Western Journal of Traditional Chinese Medicine
关键词 子宫腺肌病 异位和在位内膜 组织形态学 血管内皮生长因子 内皮抑素 微血管密度 蒲灵化瘀止痛方 adenomyosis ectopic and eutopic endometrium histomorphology vascular endothelial growth factor endostatin microvessel density Pu Ling Hua Yu Zhi Tong prescription
  • 相关文献

参考文献7

二级参考文献41

  • 1谷菲.催产素与黄体功能的关系及其在生育调节中的意义[J].国外医学(计划生育分册),1994,13(1):12-15. 被引量:3
  • 2姜展红,周应芳.子宫腺肌病实验模型的进展[J].中国妇产科临床杂志,2005,6(2):153-155. 被引量:5
  • 3刘伯宁,实用妇产科杂志,1993年,9卷,315页 被引量:1
  • 4谢汉波,中国超声医学杂志,1991年,7卷,61页 被引量:1
  • 5王友芳,中华妇产科杂志,1983年,18卷,71页 被引量:1
  • 6Ota H, Igarashi S, Hatazawa J, et al. Is adenomyosis an immune disease? Hum Reprod Update, 1998, 4∶360-368. 被引量:1
  • 7Ye ZM, SiTu L. Endometriosis.In: Wang SZ. ed. Practical Obstetrics and Gynecology. 1st ed. Beijing: The People's Hygiene Publish House, 1992.759-762.[叶之美,司徒亮. 子宫内膜异位症. 王淑贞主编. 实用妇产科学. 第1版. 北京:人民卫生出版社,1992.759-762. ] 被引量:1
  • 8Giudice LC, Tazuke SI, Swiersz L. Status of current research on endometriosis. J Reprod Med, 1998, 43(Suppl 3)∶252-262. 被引量:1
  • 9Arnold LL, Ascher SM, Simon JA. Familial adenomyosis: a case report. Fertil Steril, 1994, 61∶1165-1167. 被引量:1
  • 10Picard JK. Single-step allele-specific polymerase chain reaction HLA-DQ genotyping using ARMS primer. Hum Immunol, 1993, 38∶115-122. 被引量:1

共引文献153

同被引文献123

引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部